| Fund ID | 805-1821488569 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 99% |
| Owned by non-U.S. persons | 36% |
| Fund | Type | Gross assets |
|---|---|---|
| Cimarron Healthcare Capital Fund II, LP | Private Equity | $148.1M |
| Cimarron Healthcare Investments I, LP | Private Equity | $106.8M |
| Pv365 Co-Invest, LP | Private Equity | $26.5M |
Cimarron Continuation Fund LP reports $135.5 million in gross assets, among the top 37% of private funds by size.
Cimarron Continuation Fund LP is managed by Cimarron Healthcare Capital, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.